294 related articles for article (PubMed ID: 22244079)
1. Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease.
Marx RE; Tursun R
Int J Oral Maxillofac Surg; 2012 Mar; 41(3):283-9. PubMed ID: 22244079
[TBL] [Abstract][Full Text] [Related]
2. A commentary on "Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral Maxillofac. Surg. 41 (2012) 283-289].
Kalmar JR
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):147-8. PubMed ID: 23107998
[No Abstract] [Full Text] [Related]
3. Response to - a commentary on "Suppurative osteomyelitis, bisphosphonate induced 1 osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its 2 implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral. Maxillofac. Surg. 41 (3) (2012) 283-289].
Marx RE; Tursun R
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):148-9. PubMed ID: 23219001
[No Abstract] [Full Text] [Related]
4. Parathyroid hormone may be a promising therapy for bisphosphonate-related osteonecrosis of jaw bones.
Li YF; Hu J
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):149-50. PubMed ID: 22763138
[No Abstract] [Full Text] [Related]
5. Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy.
Favia G; Pilolli GP; Maiorano E
Bone; 2009 Sep; 45(3):406-13. PubMed ID: 19450715
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.
Hansen T; Kunkel M; Weber A; James Kirkpatrick C
J Oral Pathol Med; 2006 Mar; 35(3):155-60. PubMed ID: 16454811
[TBL] [Abstract][Full Text] [Related]
7. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the histopathological characteristics of osteomyelitis, medication-related osteonecrosis of the jaw, and osteoradionecrosis.
Shuster A; Reiser V; Trejo L; Ianculovici C; Kleinman S; Kaplan I
Int J Oral Maxillofac Surg; 2019 Jan; 48(1):17-22. PubMed ID: 30054185
[TBL] [Abstract][Full Text] [Related]
9. Bone Margin Analysis for Osteonecrosis and Osteomyelitis of the Jaws.
Qaisi M; Montague L
Oral Maxillofac Surg Clin North Am; 2017 Aug; 29(3):301-313. PubMed ID: 28709531
[TBL] [Abstract][Full Text] [Related]
10. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Wehrhan F; Gross C; Creutzburg K; Amann K; Ries J; Kesting M; Geppert CI; Weber M
J Transl Med; 2019 Mar; 17(1):69. PubMed ID: 30832685
[TBL] [Abstract][Full Text] [Related]
11. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
[TBL] [Abstract][Full Text] [Related]
12. Immunohistological expression of human ß-defensin-1 and human ß-defensin-2 in exacerbation of acute and secondary chronic osteomyelitis of the mandible.
Beck-Broichsitter BE; Dau H; Moest T; Jochens A; Stockmann P; Wiltfang J; Becker ST
J Oral Pathol Med; 2015 Feb; 44(2):88-93. PubMed ID: 24935813
[TBL] [Abstract][Full Text] [Related]
13. Medication-related osteonecrosis of the jaw, osteoradionecrosis, and osteomyelitis: A comparative histopathological study.
De Antoni CC; Matsumoto MA; Silva AAD; Curi MM; Santiago Júnior JF; Sassi LM; Cardoso CL
Braz Oral Res; 2018; 32():e23. PubMed ID: 29723337
[TBL] [Abstract][Full Text] [Related]
14. Histomorphologic characteristics of bisphosphonate-related osteonecrosis of the jaw.
Koerdt S; Dax S; Grimaldi H; Ristow O; Kuebler AC; Reuther T
J Oral Pathol Med; 2014 Jul; 43(6):448-53. PubMed ID: 24456519
[TBL] [Abstract][Full Text] [Related]
15. Increased human defensine levels hint at an inflammatory etiology of bisphosphonate-associated osteonecrosis of the jaw: an immunohistological study.
Stockmann P; Wehrhan F; Schwarz-Furlan S; Stelzle F; Trabert S; Neukam FW; Nkenke E
J Transl Med; 2011 Aug; 9():135. PubMed ID: 21843332
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate related osteonecrosis of the jaws: spontaneous or dental origin?
Pichardo SE; van Merkesteyn JP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):287-92. PubMed ID: 23953415
[TBL] [Abstract][Full Text] [Related]
17. Medication-related osteonecrosis of the jaw: Osteoclast profile in comparison with osteoradionecrosis of the jaw and osteomyelitis of the jaw.
Ngoc Thuy Tran V; Chaisuparat R
J Oral Pathol Med; 2021 Aug; 50(7):731-740. PubMed ID: 34038006
[TBL] [Abstract][Full Text] [Related]
18. Imaging of Radiation- and Medication-Related Osteonecrosis.
Mallya SM; Tetradis S
Radiol Clin North Am; 2018 Jan; 56(1):77-89. PubMed ID: 29157550
[TBL] [Abstract][Full Text] [Related]
19. [Vitamin D and bisphosphonate-related osteonecrosis of the jaw (BRONJ) ].
Hokugo A
Clin Calcium; 2012 Jan; 22(1):83-90. PubMed ID: 22201103
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-related osteonecrosis of the jaws.
Ruggiero SL
Compend Contin Educ Dent; 2008 Mar; 29(2):96-8, 100-2, 104-5. PubMed ID: 18429424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
